Agenus to Participate in Two Upcoming Investor Conferences

Agenus to Participate in Two Upcoming Investor Conferences

Agenus' Prophage heat shock protein vaccines recently generated positive data in phase 2 studies in newly diagnosed gliobastoma (the most common and most aggressive malignant primary brain cancer) and in genital herpes (an incurable infectious …

8
Like
Save

Comments

Comments are disabled for this post.